Aspen

Quick links to important sections

Aspen

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aspen

Property Description
Active ingredient Fexofenadine hydrochloride
Form Oral tablet, Oral suspension
Pharmacological class Antihistamine (Selective peripheral H1-receptor antagonist)
Common use Relief of allergic symptoms
Origin Synthetic (Active metabolite)

What is Aspen and What Type of Medicine Is It?

Aspen is a pharmaceutical agent containing the active ingredient Fexofenadine hydrochloride, and it belongs to the broad pharmacological class of antihistamines. The medicine is specifically categorized as a second-generation selective peripheral H1-receptor antagonist, which emphasizes the drug's targeted action. This selection profile provides effective relief while mitigating the central nervous system effects associated with older classes of allergy medication. Fexofenadine hydrochloride is identified as a synthetic chemical entity, making it a manufactured compound rather than a substance derived directly from natural sources. It functions as the active metabolite of terfenadine, yielding a highly selective, single-ingredient product. This mechanism is clinically recognized for providing effective, non-drowsy relief, differentiating it from first-generation options.


Composition, Forms, and General Purpose

Aspen is typically provided for patients as an oral tablet, often film-coated for ease of ingestion, though it is also commonly available as an oral suspension (liquid) formulation, a presentation often geared toward the pediatric patient group. The product's fundamental composition includes the Fexofenadine hydrochloride active ingredient combined with standard, inert pharmaceutical carriers and excipients necessary to form the tablet or suspension base. The intended route of administration is oral, ensuring the drug is absorbed systemically to achieve its effect throughout the body. The general purpose of this medicine is to offer symptomatic relief by directly blocking the action of histamine, the natural chemical released by the body's immune system that triggers the uncomfortable physical manifestations of an allergic reaction. The active substance effectively prevents histamine from binding to receptors, thereby providing relief from general allergic discomfort, such as generalized sneezing and itching.

Regulatory References

  1. Fexofenadine: MedlinePlus Drug Information

What side effects are possible with Aspen?

Possible Side Effects and Safety Information

The safety profile of Aspen (Fexofenadine hydrochloride) is documented in official regulatory sources, which classify adverse reactions based on their frequency in clinical trials and post-marketing surveillance. This information does not constitute medical advice, but describes officially listed safety characteristics.


Adverse Reactions by Frequency

Adverse reactions are organized by the system-organ class (SOC) affected. The most frequently observed effects in clinical trials in adults and adolescents (classified as Common) primarily involve the Nervous System Disorders, including headache, drowsiness (somnolence), and dizziness, as well as Gastrointestinal Disorders such as nausea. Fatigue is classified as an Uncommon effect.

Effects reported during post-marketing surveillance, for which the frequency is Not Known, include disturbances to Psychiatric Disorders (e.g., insomnia, nervousness, sleep disorders or nightmares) and Cardiac Disorders (e.g., tachycardia and palpitations).


Serious Adverse Reactions and Safety Constraints

Serious Adverse Reactions officially documented under Immune System Disorders are hypersensitivity reactions, which include manifestations such as angioedema, dyspnoea (difficulty breathing), chest tightness, and systemic anaphylaxis.

Aspen is contraindicated in individuals with a known hypersensitivity to Fexofenadine hydrochloride or any of its ingredients. A high-level safety constraint involves the timing of administration with aluminium- or magnesium-containing antacids; these should not be taken approximately two hours before or after Aspen, as they may reduce the medicine’s absorption.


Population-Specific Considerations

Administration should be undertaken with care in specific populations where limited clinical data exists, including older adults and patients with renal or hepatic impairment.

Overdose and Emergency Response

The overdose profile for Aspen (Fexofenadine hydrochloride) is based on the limited information documented in government regulatory sources regarding clinical experience. Reported manifestations following overdose have been described as infrequent.

Documented Overdose Manifestations

Reported symptoms of Fexofenadine hydrochloride overdose listed in official documentation include:

  • Drowsiness
  • Dizziness
  • Dry mouth

Emergency Actions and When to Seek Help

Official government health guidance mandates specific actions, emphasizing that immediate medical attention must be sought upon any suspicion of overdose.

Situation Mandated Action
Suspected Overdose Seek emergency medical attention or call the Poison Help line (e.g., 1-800-222-1222).
Severe Symptoms Immediately call emergency services (e.g., 911) if the person experiences life-threatening signs such as collapse, a seizure, trouble breathing, or inability to be awakened.

Supportive Management Measures

The management of Fexofenadine hydrochloride overdose is primarily symptomatic and supportive. Regulatory documents recommend that health professionals consider standard measures to remove any unabsorbed drug. It is officially noted that hemodialysis does not effectively remove fexofenadine from the blood and is considered to be of no benefit. Due to limited clinical data on overdose risk in special populations, the drug is advised to be administered with care in the elderly or patients with renal or hepatic impairment.

Therapeutic Uses of Aspen

What Aspen Treats: Main Uses and Benefits

Aspen (Fexofenadine hydrochloride) is relevant in contexts involving heightened systemic burden, such as conditions that include Seasonal Allergic Rhinitis (SAR) and Chronic Idiopathic Urticaria (CIU). It is commonly used for managing symptoms that create noticeable physiological strain.

The medication is applied across therapeutic domains involving certain distressing symptoms, primarily managing the symptom clusters associated with hay fever and persistent hives. This is applied in addressing symptoms related to physical discomfort, such as respiratory symptoms like frequent sneezing and runny nose; ocular symptoms such as itchy, watery eyes; and dermatological symptoms like skin itching (pruritus) and the appearance of wheals. It is relevant when supportive symptom management is appropriate, as it is non-sedating. This profile means it may help maintain a sense of stability when symptoms are more noticeable, supporting general well-being during symptomatic phases.

Quick Fact: Symptomatic Management of Allergic Discomfort

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Aspen?

Eligibility for Aspen (Fexofenadine hydrochloride) is strictly defined by regulatory authorities based on population-specific limitations and absolute contraindications.

Absolute Prohibition

The medicine is formally contraindicated for any individual with a documented history of hypersensitivity or allergic reaction to fexofenadine hydrochloride or any other ingredient within the medicine.

Age-Based Approval

Use is officially established for adults and adolescents (ge 12 years), and for pediatric patients in specific age ranges (e.g., 2 to 11 years) depending on the indication. The safety and efficacy for infants under 6 months of age are currently considered not established in official documents.

Conditional and Restricted Use

  • Renal Impairment: Eligibility is conditional. Patients with decreased kidney function must use the medicine with caution, as the drug's clearance is reduced.
  • Pregnancy and Lactation: Use during pregnancy is restricted to situations where the potential benefit explicitly outweighs the potential risk. Caution is advised for nursing mothers, as the substance may be present in breast milk.
  • Older Adults: Patients ge 65 years are more likely to have age-related renal impairment, which may necessitate careful consideration.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies several clinically significant interactions for this product (Codeine), primarily concerning medications that enhance central nervous system (CNS) effects or that alter the product's metabolism. The most severe constraint is the contraindication of use with Monoamine Oxidase Inhibitors (MAOIs). Co-administration is prohibited if an MAOI (including phenelzine, tranylcypromine, or moclobemide) has been taken within the preceding ten days due to the risk of severe adverse effects.

Use with Caution

Caution and medical consultation are required when combining this product with other drugs that cause CNS depression, as this may lead to additive effects. These interacting drug categories include:

  • Other Opioid Analgesics
  • Medicines used to help you sleep or relieve anxiety (sedatives and anxiolytics)
  • Antidepressant medicines (other than MAOIs)
  • Antihistamines (specifically sedating types)
  • Medicines used to relax muscles

Specific medicines noted in official labeling that may require caution or adjustment include Cimetidine, which can increase the drug’s effects, and Metoclopramide. Conversely, the effects of this product may be blocked by Naloxone or Naltrexone.

Mechanism of Action

Aspen is a selective inhibitor of the Janus kinase (JAK) family of enzymes. Aspen specifically binds to and inhibits JAK-1, JAK-2, and JAK-3. This action limits the intracellular signaling cascade initiated by multiple pro-inflammatory cytokines, resulting in the modulation of the downstream inflammatory pathway. The inhibition prevents the phosphorylation of STAT (Signal Transducers and Activators of Transcription) proteins. By disrupting this phosphorylation, Aspen suppresses subsequent STAT dimerization, nuclear translocation, and gene transcription. This mechanistic cascade ultimately leads to a reduction in the synthesis and release of inflammatory mediators and limits the proliferation of certain inflammatory cell populations. Furthermore, the differential inhibition profile across the JAK family modulates key signaling pathways responsible for the activation and function of osteoclast cells.

Dosage and Administration Information

Official Administration Guidelines for Aspen (Aspirin)

The administration of this medication, often known as Aspirin (Acetylsalicylic Acid), is governed by official regulatory guidelines. These instructions detail the required route, dosing, and procedural steps for proper use, strictly avoiding therapeutic context or recommendations.


Administration Scope

Attribute Official Regulatory Instruction
Route of Administration Oral (by mouth)
Standard Dosing Adults and children 12 years and over typically take 325 mg to 650 mg every 4 to 6 hours.
Maximum Frequency Do not exceed 12 tablets (325 mg strength) in a 24-hour period.
Age-Specific Use Do not administer to children under 12 years of age unless directed and supervised by a physician.

Procedural Steps

The established procedure for taking this medication focuses on reducing gastric irritation and ensuring consistent absorption:

  • Preparation: The standard tablet is swallowed whole; do not crush or chew forms designated as extended-release or enteric-coated.
  • Timing: To mitigate the potential for stomach upset, the dose must be administered with food or milk.
  • Procedural Condition: Each dose is to be taken with a full glass of water.

Missed Dose Instructions

If a dose is missed, it should be taken when the next dose is due. Do not take a double dose to compensate for the skipped amount. Continue the schedule as originally intended by the established frequency pattern.


The regulatory instructions define a clear protocol: oral ingestion with specific timing constraints relative to meals, and strict limits on frequency and age-group eligibility. This structure provides the authorized framework for safe and controlled use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aspen (Fexofenadine hydrochloride)


Evidence for Use in Seasonal Allergic Rhinitis (SAR)

The body of research evaluating Aspen for Seasonal Allergic Rhinitis (SAR), commonly known as hay fever, is extensive. This evidence base is primarily built upon numerous short-term Randomized Controlled Trials (RCTs). In these controlled settings, Aspen was studied for short time intervals, typically two to four weeks, to understand how symptoms change over time when compared to an inactive placebo. The studies primarily used patient-reported outcomes, which are measurements that track the severity of symptoms, such as sneezing, runny nose, and itching of the eyes or throat, as reported by participants.

Findings describe patterns observed in the studies where measurements related to physical discomfort changed over the study period, contrasting with the changes observed in the placebo groups. Furthermore, research explored the onset of effect. Specific studies conducted in controlled Environmental Exposure Units (EEUs) described patterns where changes in symptom measurements were observed shortly after administration.


Evidence for Use in Chronic Idiopathic Urticaria (CIU)

Aspen was also evaluated in research contexts involving Chronic Idiopathic Urticaria (CIU), a condition marked by functional limitations such as persistent hives and itching. This evidence largely comes from multicenter, placebo-controlled trials where studies monitored changes in patient-reported outcomes related to physical discomfort over treatment periods lasting four to six weeks. Key measurements in these studies included the Daily Mean Pruritus Score (MPS) for itching severity and the Daily Mean Number of Wheals (MNW) score.

Across controlled trials, analyses described patterns where both the severity of itching and the mean number of wheals were consistently measured as having changed in the observed populations. These short-term research findings help contextualize how patients reported their experience during periods of heightened symptom activity.


What is Still Uncertain About Aspen's Research Record

A key research limitation frame is the duration of studies. As noted, most pivotal studies were short-term, meaning that long-term effects on disease progression or quality of life are not fully established. Additionally, the results apply only to the populations studied. Data for certain complicated groups, such as those with severe or treatment-refractory conditions, remain insufficient and represent a research gap. While the body of evidence for the main indications is highly consistent across numerous studies, certain questions regarding dosing for non-responsive patients or the long-term patterns in the youngest children indicate that research is ongoing in these specific areas.

Key Studies & References

  1. Fexofenadine Oral Tablet (NIH MedlinePlus Drug Information)
  2. FEXOFENADINE HYDROCHLORIDE Tablet Label (DailyMed - NIH/NLM)
  3. Allergic rhinitis: assessment and management (NICE Guideline NG85)

Frequently Asked Questions (FAQ)

Common questions about Aspen (FAQ)

Q: What condition is Aspen officially approved to treat?

Official regulatory documents indicate that Aspen is approved for the relief of symptoms related to Seasonal Allergic Rhinitis, commonly known as hay fever. It is also indicated for the management of the skin symptoms of Chronic Idiopathic Urticaria, which is persistent hives without an identifiable cause.

Q: How does Aspen relate to older medicines used for the same condition?

Aspen is classified as a second-generation antihistamine. This classification means it is designed to selectively block H1-receptors outside of the brain. This characteristic is noted in regulatory pharmacology descriptions as mitigating central nervous system effects associated with older classes of allergy medication.

Q: What is the official information regarding Aspen and consumption of alcohol?

While regulatory labeling does not explicitly forbid alcohol use, the product’s side effect profile does include drowsiness and dizziness. Because alcohol is a central nervous system depressant, co-consumption may increase these effects. Regulatory warnings indicate that caution is advised when using substances that may cause central nervous system depression.

Q: Are there any foods or drinks that should be avoided while taking Aspen?

Official drug labeling advises against taking Aspen with fruit juices, specifically listing apple, orange, or grapefruit juice. Regulatory data indicates that these juices can interfere with how the medication is absorbed, which may reduce its effectiveness.

Q: Can Aspen be taken at the same time as my other prescription medications?

Regulatory documents list several drug categories that may require medical consultation or monitoring if taken concurrently with Aspen, including certain anti-infectives. Official records prioritize significant interactions. For all other medications, the product information advises that caution is required.

Q: What is the recommended period of time to evaluate if Aspen is working?

The clinical studies that support the use of Aspen typically monitor symptom improvement over short periods. For allergic rhinitis, trials generally observe changes over 2 to 4 weeks. If symptoms do not improve after this period, re-evaluation by a healthcare provider may be necessary.

Q: What is the reported half-life of Aspen in the body?

According to official clinical pharmacology data, the mean terminal elimination half-life of Aspen’s active ingredient is approximately 11 to 15 hours in healthy adult subjects. The half-life is the time it takes for half of the medicine to be cleared from the body.

Q: What are the differences between the various strengths or formulations of Aspen?

Aspen is manufactured in different forms and dosages to suit various patient needs. The medicine is commonly available as an oral tablet in strengths such as 30 mg, 60 mg, and 180 mg, as well as an oral suspension (liquid) formulation.

Q: Is there any official guidance on driving or operating machinery while taking Aspen?

Due to the listed side effects of drowsiness and dizziness, official labeling advises caution. Official guidance notes that patients should be aware of the medication's effects before participating in activities that require mental alertness.

Q: Why do some regulatory bodies require special monitoring for Aspen users?

Official documents cite that the medicine is largely eliminated through the kidneys. Therefore, special monitoring and caution are noted for patients with decreased kidney function (renal impairment), as the drug may stay in the body longer than usual.

Q: Does Aspen cause any significant changes to mood or energy levels?

Official regulatory documents categorize side effects related to mood and energy. Common side effects include fatigue and drowsiness. Rare reports in post-marketing surveillance have noted effects such as insomnia and nervousness.

Q: How is Aspen processed and eliminated from the body?

Regulatory information indicates that Aspen is minimally processed by the liver. It is predominantly eliminated unchanged from the body. Most of the medicine leaves the body via the feces (biliary excretion) and a smaller amount is removed through the urine (renal excretion).

Q: Is Aspen a medication taken long-term or short-term?

The official documentation supports the use of Aspen to manage symptoms for the duration of exposure to the allergen, or for the active phase of chronic hives. While clinical studies are typically short-term, the duration of treatment is guided by the official indication for use and the nature of the condition.

Q: Do I need a special prescription to get Aspen?

Depending on the country and the specific dosage, Aspen may be available in some formulations as an Over-The-Counter (OTC) medication. However, other strengths or specialized forms may require a doctor’s prescription (Rx).

Q: Does Aspen have a generic version available?

Yes. According to drug regulatory databases, the active ingredient fexofenadine hydrochloride is widely available from various manufacturers as a generic product, in addition to the brand-name medicine.

Q: Can Aspen affect my appetite or weight?

Regulatory labeling and clinical trial data do not specifically list weight gain, weight loss, or changes in appetite as a common adverse reaction for Aspen.

Q: Does Aspen interact with common over-the-counter pain relievers?

Official regulatory warnings note that interactions have been reported with Acetylsalicylic acid (aspirin). Warnings for other common over-the-counter pain relievers (like ibuprofen or acetaminophen) are generally not cited in the official labeling.

Q: Are there any specific vitamins or herbal supplements that are known to interact with Aspen?

Official regulatory warnings primarily focus on interactions with other prescription drugs and antacids. If you are taking any vitamins or herbal supplements, the official product labeling should be consulted for comprehensive interaction details.

Q: Is it safe to take Aspen if I am also on blood pressure medication?

Official regulatory documents do not list common blood pressure medications (antihypertensives) as a primary contraindication or requiring explicit caution with Aspen. Official documentation advises caution when combining any medications and does not specifically address this interaction.

Q: What is the expected duration of action for one dose of Aspen?

According to official pharmacodynamic studies, the antihistamine effect of a single dose of Aspen is generally observed within 1 hour of administration. The therapeutic effect is still evident 12 hours post-dose, which supports its common once or twice-daily dosing regimen.

Q: Why is Aspen sometimes described as a 'controlled substance'?

This medicine is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or equivalent international bodies. Controlled substance status is typically assigned to drugs with a recognized potential for dependence or abuse.

Q: Where can I find the full official prescribing information for Aspen?

The full official drug labeling, which includes complete prescribing and patient information, is accessible on government-operated health websites. These resources include the DailyMed and the FDA Drugs@FDA database in the U.S.

Q: Are there any ongoing research studies for additional uses of Aspen?

Information regarding ongoing research is publicly maintained in registries such as the NIH ClinicalTrials.gov. This database lists studies sponsored by both governmental and private entities to explore the potential uses of medications.

Q: Is Aspen a medication that requires regular blood tests?

Official regulatory warnings for Aspen’s active ingredient do not typically include requirements for routine monitoring through regular blood tests. Such testing is not noted as a standard safety measure for this medication.

Q: Does Aspen affect fertility in men or women?

Animal studies have been conducted and have not shown evidence of impaired fertility related to the active ingredient. As is common, human data is limited, and concerns regarding fertility should be reviewed with a healthcare professional.

Q: What are the risks associated with stopping Aspen suddenly?

The official labeling does not include a warning about specific risks associated with suddenly discontinuing the medication. This suggests that abrupt cessation is not associated with an immediate, recognized danger.

Q: Is Aspen known to cause withdrawal symptoms?

Official regulatory labeling for the active ingredient does not list withdrawal symptoms that occur when a person stops taking the medicine. This type of symptom profile is not associated with this class of medication.

Q: Is it possible for someone to build a tolerance to Aspen over time?

Clinical studies have examined the potential for tolerance, which is when the body needs increasing amounts of a drug to get the same effect. Official data from clinical trials examining the antihistamine effect found no evidence of tolerance after 28 days of regular dosing.

How should Aspen be stored and disposed of?

The storage and disposal of Aspen (Fexofenadine Hydrochloride) are governed by specific regulatory requirements to ensure product stability and safety. The medicine must be stored at 20 C to 25 C (68 F to 77 F), with protection from excessive moisture. The oral suspension must be protected from freezing.

Regulatory labeling requires that the product be kept in its original container and strictly out of the reach of children. Unused or expired medication should not be flushed down the toilet. Disposal must follow official guidelines, which recommend using a drug take-back program or mixing the medicine with an unappealing substance for household trash disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aspen found in:

A-Z Index: